A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

March 6, 2025

Study Completion Date

March 6, 2025

Conditions

Healthy Participants

Interventions

DRUG

AZD5004

Participants will receive oral tablets of AZD5004 in Part A and Part B of the study as per arms they are assigned.

DRUG

Placebo

Placebo will be administered as an oral tablet once daily.

Trial Locations (1)

Research Site, Brooklyn